Nanopharm has a total of 45 patents globally, out of which 24 have been granted. Of these 45 patents, 53.33 % patents are active. United Kingdom is where Nanopharm has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of Nanopharm.
Nanopharmis founded in 2002, is a subpart of Aptar Pharma company. The company pharmaceutical contract research organization (CRO) specializing in the development of orally inhaled and nasal drug products (OINDPs). Leveraging expertise in aerosol science, formulation development, and advanced analytical testing, the company helps pharmaceutical and biotechnology companies accelerate product development and regulatory approval.
Nanopharm is committed to delivering innovative drug development solutions that improve efficiency, reduce development risks, and bring high-quality inhaled and nasal therapies to patients faster.
In July 2026, Aptar Pharma announced that its Nanopharm facility received MHRA GMP certification, marking a significant milestone in strengthening its integrated pharmaceutical services offering. The certification enables Nanopharm to support GMP-compliant manufacturing for clinical trials, complementing its existing expertise in orally inhaled and nasal drug product (OINDP) development, formulation, analytical testing, and regulatory support.
This milestone further enhances Aptar Pharma’s ability to provide end-to-end drug development solutions and reinforces its commitment to accelerating innovative inhaled and nasal therapies for pharmaceutical and biotechnology customers.
Do read about some of the most notable patents of Nanopharm covered in this article. You can also explore Nanopharm’ patent portfolio, worldwide patent filing activity, patent filing trends over the years, and many other statistics related to its patent portfolio.
How many patents does Nanopharm have?
Nanopharm has a total of 45 patents globally. These patents belong to 10 unique patent families. Out of 45 patents, 39 patents are active.
How Many Patents did Nanopharm File Every Year?
| Year of Patents Filing or Grant | Nanopharm Applications Filed | Nanopharm Patents Granted |
| 2026 | – | 1 |
| 2025 | 4 | 9 |
| 2024 | 5 | 4 |
| 2023 | 5 | 3 |
| 2022 | 3 | 1 |
| 2021 | – | 5 |
| 2020 | 1 | 1 |
| 2019 | 14 | – |
| 2016 | 12 | – |
| 2015 | 1 | – |
How many Nanopharm patents are Alive/Dead?
Worldwide Patents
How Many Patents did Nanopharm File in Different Countries?
Top Countries in which Nanopharm Filed Patents
| Country | Patent |
| United Kingdom | 8 |
| United States of America | 6 |
| Europe (EPO) | 4 |
| China | 4 |
| Australia | 3 |
| Germany | 3 |
| India | 3 |
| Italy | 2 |
| Spain | 1 |
| Austria | 1 |
| Brazil | 1 |
| Canada | 1 |
Track Every Patent Move in Real Time Across 70+ Jurisdictions with Elixir
Where are Research Centres of Nanopharm Patents Located?
Best Nanopharm Patents
WO2017051180A1 is the most popular patent in the Nanopharmportfolio. It has received 34 citations so far from companies like Companies, Honeywell and Proveris Scientific Corporation.
Below is the list of most cited patents of Nanopharm:
| Publication Number | Citation Count |
| WO2017051180A1 | 34 |
| US10724928B2 | 3 |
| WO2021093975A1 | 2 |
| WO2023139381A1 | 1 |
| CN108027303B | 1 |
What Percentage of Nanopharm US Patent Applications Were Granted?
Nanopharm (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 71.43%
Below are the key stats of Nanopharmpatent prosecution at the USPTO.
Which Law Firms are managing US Patents for Nanopharm?
| Law Firm | Total Applications | Success Rate |
| Pabst Patent Group Llp | 3 | 33.33% |
| Kilyk & Bowersox PLLC | 2 | 100.0% |
| Sughrue Mion Pllc | 2 | 100.0% |
| Ralph A Loren | 1 | 100.0% |
What are Nanopharm key innovation segments?
What Technologies are Covered by Nanopharm?
The chart below distributes patents filed by Nanopharm